Hepatitis A Vaccine Market Growth Boosted by WHO 2030 Targets and Rising Global Travel
The Hepatitis A vaccine market, valued at US$ 759.01 million in 2024, is projected to reach US$ 948.16 million by 2034. Growth is driven by rising outbreaks, immunization awareness, and travel. Asia-Pacific leads, with North America growing fastest; key players include GSK, Merck, and Sanofi.
Last Updated : 21 April 2026
Category: Therapeutic Area
Insight Code: 5301
Format: PDF / PPT / Excel